Work

Proteasome Regulator Marizomib (NPI-0052) Exhibits Prolonged Inhibition, Attenuated Efflux, and Greater Cytotoxicity than Its Reversible Analogs

Year: 2011

Type: article

Source: Journal of Pharmacology and Experimental Therapeutics

DOI: 10.1124/jpet.110.177824

Authors: Amanda Obaidat, Jeffrey Weiss, Brett Wahlgren, Rama R. Manam, Venkat R. Macherla, Katherine McArthur, Ta-Hsiang Chao, Michael A. Palladino, G. Kenneth Lloyd, Barbara C. Potts, Salvatore J. Enna, Saskia T.C. Neuteboom, Bruno Hagenbuch

Institutions: University of Kansas Medical Center, The University of Kansas Cancer Center

Language: English

Topic: Ubiquitin and proteasome pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: American Association for Cancer Research, National Institutes of Health, National Institute of General Medical Sciences, National Institute of Environmental Health Sciences, National Center for Research Resources

Awards: G1958400685, G2850908965, Nuclear Receptors in Liver Health and Disease, G4686375030, Molecular Characterization of Hepatic Organic Anion Transporting Polypeptides, Training Program in Environmental Toxicology, G9000099149

OpenAlex ID: W2072898309

FWCI: 2.193

Cites: 22

Cited by: 32

Related to: 10